← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Praetego, Inc.
Durham, NC
$5,752,037
Total funding
4
Grants
Funding over time
peak $1.6M · FY2018–23$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,752,037 · 4
By mechanism
R42$2,598,154 · 1
R44$2,555,118 · 1
R43$299,825 · 1
R41$298,940 · 1
Investigators at Praetego, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Amadorins for Ameliorating Alzheimer's Disease and Related Dementias (ADRD)$1,259,042
R44 · FY2022 · AG
Amadorins for Ameliorating Alzheimer's Disease and Related Dementias (ADRD)$1,246,076
R44 · FY2023 · AG
Development of novel Amadorins for Diabetic Peripheral Neuropathy$895,610
R42 · FY2021 · DK
Development of novel Amadorins for Diabetic Peripheral Neuropathy$874,423
R42 · FY2020 · DK
Development of novel Amadorins for Diabetic Peripheral Neuropathy$458,155
R42 · FY2021 · DK
Development of novel Amadorins for Diabetic Peripheral Neuropathy$369,966
R42 · FY2022 · DK
Development of novel Amadorins for Diabetic Peripheral Neuropathy$299,825
R43 · FY2018 · DK
Amadorins as a Novel Oral Therapeutic for Diabetic Retinopathy$298,940
R41 · FY2023 · EY
Amadorins for Ameliorating Alzheimer's Disease and Related Dementias (ADRD)$50,000
R44 · FY2023 · AG